The UK pharmacy sector is in a period of change. Rising costs, tighter NHS funding, and new compliance requirements are creating challenges for many owners. At the same time, demand for quality pharmacies remains strong, with first-time buyers, GP investors, and established operators all showing interest.
This raises an important question for anyone thinking about a transaction: Is the current market better for buyers or for sellers? Understanding where things stand today can help you decide on the right time and the right approach, whether you are looking to buy your first pharmacy or considering putting your business on the market.
Recent Trends in the UK Pharmacy Market
The pharmacy market has been active over the past year, with sales activity increasing despite the wider pressures facing the sector. Christie & Co reported more than 220 pharmacy transactions in the twelve months to November 2024, more than double the level of the previous year. A significant share of these deals involved first-time buyers, reflecting a growing appetite among individual pharmacists and GP investors to take ownership. Independent consultants such as Hutchings also found that more than half of their sales in 2024 went to first-time buyers, showing how the profile of purchasers is shifting.
Prices, however, have been under pressure. The average sale price fell by just over six per cent compared to 2023, and on completion, pharmacies were typically achieving around 91 per cent of their asking price. This suggests that while demand remains strong, buyers are negotiating harder and taking a more cautious approach to valuation. At the same time, corporate disposals have made up a notable proportion of transactions, with several of the larger groups choosing to offload branches. This has created opportunities for smaller operators to expand, but it also reflects the financial strain felt across the sector.
Closures continue to be a concern. In 2024, almost 250 community pharmacies in England shut their doors, an average of nearly five each week. The overall number of community pharmacies has fallen steadily in recent years, dropping from over 10,800 in 2021 to just over 10,000 by the beginning of 2025. Alongside these closures, an independent economic review commissioned by the NHS found that nearly four in five pharmacies were not financially sustainable in the short term, with the cost of delivering services far outweighing the funding provided.
Despite these challenges, well-run pharmacies with stable prescription volumes, good locations, and diversified income streams continue to attract strong interest. Buyers are scrutinising performance and risk more carefully, but demand for quality businesses is still very much present.
Challenges Shaping the Pharmacy Market in 2026
Several pressures are shaping the current pharmacy landscape, and they go a long way toward explaining why the market feels uncertain for both buyers and sellers.
One of the biggest issues is funding. An independent economic review commissioned by the NHS found that the cost of delivering pharmaceutical services in England is billions of pounds higher than the funding provided. This gap means many pharmacies are struggling to cover their operating costs, and almost 80 per cent are considered financially unsustainable in the short term. For owners, this adds real pressure to cash flow and future planning.
Rising costs are another key challenge. Wages, energy bills, and drug supply prices have all increased sharply, leaving profit margins thinner than ever. Even pharmacies with steady prescription volumes are feeling the impact of these higher overheads. For some businesses, this has been the deciding factor in closing or selling up.
Regulatory and contractual uncertainty also plays a part. The NHS contractual framework continues to evolve, with funding for services like Pharmacy First providing opportunities but not always offsetting the wider financial pressures. Owners and buyers alike are questioning how sustainable current funding levels will be in the medium to long term.
Together, these pressures mean that while there is plenty of activity in the market, the conditions are challenging. Buyers must weigh up the risks carefully, and sellers need to present their businesses in the strongest possible light to achieve the right price.
Signs the UK Pharmacy Market Is Favouring Buyers
Several indicators suggest the current market leans towards buyers, particularly for smaller or financially stretched pharmacies. The fall in average sale prices compared with 2023 shows that buyers are negotiating more firmly, often completing deals at less than the original asking price. For anyone looking to enter the market, this creates opportunities to secure a business at a more accessible valuation.
Corporate disposals are another sign that the balance is tilting toward buyers. Large groups have been offloading branches to cut costs or restructure, which has led to a greater supply of pharmacies coming onto the market. When supply rises, buyers often gain the upper hand in negotiations, especially if a seller is motivated to move quickly.
Distressed sales are also playing a role. Rising costs and reduced margins have left some independents under pressure to sell, which again favours buyers willing to take on risk. However, it is important to remember that while purchase prices may be lower, the underlying financial pressures that led to those sales do not disappear. Careful due diligence remains essential.
Why Strong Pharmacies Still Achieve Strong Prices in 2026
Although the market shows signs of favouring buyers, it is not one-sided. Pharmacies that are well run and financially robust continue to command strong interest. Businesses with steady prescription volumes, good locations, and additional income streams from services such as vaccinations or travel health clinics are particularly attractive. Buyers are willing to compete for these pharmacies, which can drive valuations closer to the asking price.
Competition among first-time buyers is also helping certain sellers. With many pharmacists and healthcare professionals keen to take ownership, demand for quality sites has remained resilient. In some cases, multiple offers are received, giving sellers the chance to negotiate on both price and terms.
In short, while weaker businesses may struggle to achieve their desired valuation, sellers with strong pharmacies are still in a position of strength. The market is rewarding those who can demonstrate stability, efficiency, and potential for future growth.
What the Pharmacy Market Means for Buyers and Sellers
For buyers, today’s market presents genuine opportunities. Lower average sale prices and an increase in pharmacies coming to market make it possible to acquire a business at a more accessible entry point. At the same time, the financial pressures behind many of these sales mean buyers must proceed carefully. Detailed due diligence, clear financial modelling, and a close look at NHS income streams are all essential before committing.
For sellers, the message is about preparation and realism. Pharmacies that can show consistent performance, diversified services, and efficient operations are still attracting strong offers. However, owners whose businesses are under pressure may need to adjust expectations around valuation and be open to negotiation. Presenting the pharmacy in the best possible light, supported by accurate accounts and compliance records, will help maintain buyer confidence and secure the right outcome.
Whether you are buying or selling, the current market requires a clear strategy and professional support. Those who approach the process with good preparation and realistic goals are the ones most likely to succeed.
The UK pharmacy market is shifting, and that creates both opportunities and risks. Buyers are finding more opportunities to purchase, while sellers who prepare well can still achieve strong results. What matters most now is clarity, understanding how the market is moving and what that means for your next step.
At Healthcare Plus, we work alongside pharmacy owners and buyers to cut through the complexity. Whether you are planning an exit or looking to invest, we provide the insight and support needed to approach the market with confidence and make decisions that stand the test of time.
